Supplemental Methods

CRISPR/Cas9-mediated knockout
NAMEC8R and 4175 with PODXL knockout (KO) cell lines were generated by lentiviral transduction with the lentiCRISPRv2 backbone (Sanjana et al., 2014) 
Q5 site-directed mutagenesis
Rescue of PODXL KO cells with active Cas9 was achieved by re-expression of PODXL containing a silent mutation in the PAM recognition site previously used by Cas9. For this purpose, the Gateway entry vector pENTR233_PODXL was used to produce pENTR233_PODXL G273C using the Q5 site-directed mutagenesis kit (NEB #E0554S). pENTR233_PODXL was provided by the ORFeome Collaboration (PlasmID clone ID HsCD00378744, PMID 17207965 and 154893350; Storage and distribution provided by the PlasmID Repository at Harvard Medical School and funded in part by NCI Cancer Center Support Grant #NIH 5 P30 CA06516). Primers were designed using the NEBaseChanger Tool (NEB; see Table) . Successful point mutation was confirmed by Sanger DNA sequencing. pENTR233_PODXL G273C was then recombined into the Gateway destination vector pLEX_307 (pLEX_307 was a gift from David Root; Addgene plasmid #41392) containing a V5 tag using Gateway LR clonase Enzyme mix (ThermoFischer Scientific #11791019). Other PODXL mutants were produced from pENTR233_PODXL G273C using the Q5 site-directed mutagenesis kit. The PODXL mutant dEC-PODXL that carries a deletion of the extracellular domain was additionally tagged with V5. The DNA sequences of the PODXL mutants were confirmed by sequencing and the gateway entry vectors were recombined into the Gateway destination vector EBFP membrane. Lentivirus was produced of all constructs using standard methods (Stewart et al., 2003) Addgene plasmid #8455 (Stewart et al., 2003) pCMV-VSV-g (Envelope plasmid for Lentiviral constructs)
Addgene plasmid # 8454 (Stewart et al., 2003) pUMVC (Packaging plasmid for Retroviral constructs)
Addgene plasmid # 8449 (Moffat et al., 2006) pFUW-LPT2 Zeb1 Z. Keckesova pFUW-LPT2 hSnail Z. Keckesova (Lu et al., 2014 Nov) pLEX_307
Addgene plasmid #41392 pcDNA3.1(+)/Luc2=tdT
Addgene plasmid #32904 pENTR1A Dual Selection Vector ThermoFischer Scientific #A10462 lentiCRISPRv2
Addgene plasmid #52961 (Sanjana et al., 2014) 
Western Blot Analyses
Cell were harvested in RIPA buffer containing phosphatase inhibitors 2/3 (1:100; Sigma-Aldrich #P5726 & #P0044) and protease inhibitor (1:100; Sigma Aldrich #P8340). NUPAGE Bis-Tris Mini Gels (ThermoFischer Scientific) were transferred to PVDF membranes using XCell II mini cell apparatus and blocked in 5% non-fat dry milk/TBS-T. Membranes were incubated with antibodies overnight, as recommended for each antibody protocol. Membranes were washed with TBS-T, and incubated with secondary antibody in 5% non-fat dry milk/TBS-T for 1 hour at room temperature, followed by washing and detection via ECL reagent. 
Antibodies for Western Blot Analyses
FACS
The cells were prepared and stained according to standard protocols and suspended in 5% IFS/PBS. For staining of PODXL, cells were detached using an enzyme-free cell dissociation buffer (ThermoFischer Scientific, #13151014) instead of trypsin. Cells were sorted on BD FACSAria SORP and analyzed on BD LSRII, using BD FACSDiva Software (BD Biosciences). Data were processed and analyzed using Flowjo (Flowjo LLC). Antibodies used are ms anti-PODXL-Alexa647 (Nuromab; CureMeta), CD44-PE-Cy7 (Biolegend #103029), EpCAM-PacificBlue (Biolegend #324218), CD104-PE (Biolegend #327808) at 1:100 dilution and CD24-FITC (BD Pharmingen #555427) at 1:30 dilution for 30 minutes in 5% IFS/PBS.
Migration, invasion and transendothelial migration assays
For transendothelial migration assays, FluoroBlok transwells (Corning Life Sciences, #351152) were coated with collagen, seeded with 5x10 5
HUVECs and cultured at 37°C, 5% CO2 for 24 h. Tightness of the endothelial monolayer was tested on two HUVEC-coated transwells by FITC-Dextran (EMD Millipore #90328) permeability following the guidelines of the FITC-Dextran vascular permeability assay (EMD Millipore #ECM644) and compared to an empty transwell. The other transwells containing HUVEC monolayers were seeded with 5x10
For migration assays, 5x10 4 cancer cells were seeded into transwells (Corning Life Sciences, #353097). For invasion assays, transwells containing dehydrated matrigel (Corning Life Sciences, #354483) were rehydrated according to protocol prior to cancer cell seeding and then seeded like migration assays. The seeded transwells were incubated for 24 h, fixed in methanol and transmigrated cancer cells were stained using crystal violet (0.01%) in 20% methanol. Per transwell, 3 fields of view at 10x magnification were counted using the Axio Observer A1 microscope (Zeiss). In order to correct for differences in cell numbers due to seeding errors and proliferation, cancer cells of the same cells solution used to seed the migration/invasion/transendothelial migration assay were seeded for a proliferation assay for 24 h and the average number of cells per cell type was determined using CyQuant (Thermo Fisher Scientific, C7026). The normalized cell counts were then used to correct the number of transmigrated cells and data were plotted using GraphPad Prism.
Proliferation assay
Proliferation assays were conducted in 96-well plates using CyQuant (Thermo Fisher Scientific, C7026), according to the manufacturer's recommendations, to measure DNA content in each well during a 5-d time course. The first day after seeding was counted as Day 0 and used for normalization of values obtained from plates collected at subsequent time points.
Immunofluorescent staining of cancer cell migration through HUVEC monolayers cultured on collagen I gels
For immunofluorescent staining of proteins, samples were fixed after 3 h of co-culture using 4 % PFA for 20 min at room temperature (RT) and stained as previously described (Artym and Matsumoto, 2010) . Primary antibodies used were mouse anti-PODXL (Santa Cruz, #sc-23904), mouse anti-Ezrin (Santa Cruz, #sc-58758) at 1:50 and rabbit anti-Ezrin (Cell Signaling Technology #3145) at 1:50. Cells were imaged using the LSM710 confocal microscope (Zeiss). Multiple z-stacks were acquired per well at different locations using a 63x oil objective and analyzed using Imaris software (Bitplane).
Immunohistochemistry
Tissue microarrays BR1503e and BRM961a were purchased from US Biomax, Inc.. Slides were rehydrated in a descending alcohol series. Antigen retrieval of tissue sections was performed at 125°C for 20 min in pH 6.0-Sodium citrate buffer, washed with PBS and endogenous peroxidase activity was blocked using BLOXALL endogenous peroxidase and alkaline phosphatase blocking solution (Vector Laboratories, #SP6000). After washing, endogenous streptavidin/biotin was blocked using a streptavidin/biotin blocking kit (Vector Laboratories SP-2002) . Following another washing step, the microarrays were blocked using Background Terminator (Biocare Medical #BT967 H,L) for 7 min at RT to reduce nonspecific antibody binding. Slides were then washed three times. All wash steps were performed with PBS. Staining was performed at 4°C over night using biotin-labeled monoclonal mouse anti-human PODXL antibody (1:50 in PBS; CureMeta). Following three wash steps, slides were incubated with ABC reagent (Vector Laboratories, Vectastain Elite ABC-HRP kit (Peroxidase, mouse IgG) #PK-6102) for 30 minutes at room temperature. Peroxidase reaction was performed using ImmPACT DAB peroxidase substrate (Vector Laboratories #SK-4105) and the reaction was stopped with diH2O. Tissues were then counterstained using hematoxylin QS (Vector Laboratories #H-3404). Following dehydration in an ascending alcohol series, slides were mounted in Vectamount Mounting Medium (Vector Laboratories #H-5000). For imaging, slides were scanned using the Aperio Digital Pathology slide scanner (Leica Biosystems) and analyzed using the Aperio Image Scope (Leica Biosystems) software.
Immunofluorescence (IF) on suspended cells
Cancer cells were harvested using an enzyme-free cell dissociation buffer (ThermoFischer Scientific, #13151014) and pelleted at 3000 rpm for 5 min by centrifugation. The cells were then fixed by addition of 4% PFA for 10 min at RT under rotation. Following two washing steps with PBS, cells were blocked in 50 µl blocking buffer (10 % HS + 3 % BSA) for 30 min at RT under rotation. Next, the primary antibodies ms anti-PODXL-Alexa647 (Nuromab, CureMeta) or ms anti-V5 tag [GT1071] (GeneTex #GTX628529) were diluted at 1:50 in blocking buffer and 50 µl were added to each sample. Samples were incubated over night at 4°C under rotation. On the next day, cells were washed four times with PBS and then stained with DAPI (1:1000 in blocking buffer) for 10 min at RT or with DAPI (1:1000 in blocking buffer) and gt anti-ms A647 (Invitrogen #A21235; 1:200 in blocking buffer). Cells were washed three times with PBS and then resuspended in 10 µl ProLong Gold antifade mounting medium with DAPI (Lifetech #P36931) and loaded onto histology slides and coverslipped. Samples were air dried and stored at 4°C prior to imaging with LSM700 confocal microscope (Zeiss).
Quantitative Real time PCR (qRT-PCR)
RNA extraction was performed on collected cell pellets according to the guidelines of the Qiagen RNeasy® Plus extraction protocol. The purified RNA was reverse transcribed into cDNA using a high-capacity cDNA reverse transcription kit (Applied Biosystems #4368814) according to the manufacturers guidelines. In total, 1 µg RNA per sample was reverse transcribed using the MyCycler Thermal Cycler. In order to analyze the expression levels of several proteins, the cDNA was diluted by the addition of 80 µl H2O to a final volume of 100 µl. For each reaction 2 µl of each cDNA sample were mixed with 10 µl LightCycler 480 SYBR Green I Master mix (2 x), 6.4 µl H2O and 1.6 µl of forward and reverse primer mix (10 µM forward + 10 µM reverse primer). All samples were loaded on a 384 well plate and analyzed by quantitative real time PCR using the Roche Light cycler 480 II. The mRNA levels of genes of interest (e.g. PODXL) were normalized to the mRNA levels of the housekeeping gene GAPDH. The data were then analyzed using Excel and plotted with GraphPad Prism.
Primers for qRT-PCR
Gene
Forward Reverse 
GAPDH
GGTCTCCTCTGACTTCAACA GTGAGGGTCTCTCTCTTCCT
SNAI2
Bioinformatic analysis of mRNA sequencing data
In order to look for cell surface proteins that are differentially expressed in cells prior to and after an EMT, a previously published mRNA sequencing data set was analyzed (Pattabiraman et al., 2016) . The data set was filtered for genes that had a mean number of reads equal to or greater than 200 (=9797 genes). Furthermore, only genes that were upregulated at least 3-fold on a log2 scale were included (256 genes). Gene expression data were clustered using Cluster 3.0 and visualized using Java TreeView (de Hoon et al., 2004; Saldanha, 2004) . We selected several candidate genes that might be involved in the regulation of adhesion to endothelial cells, transendothelial migration and invasion of these cells, focusing in particular on cell-surface proteins.
